nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—PDE5A—pulmonary artery—systemic scleroderma	0.0627	0.233	CbGeAlD
Pentoxifylline—PDE5A—artery—systemic scleroderma	0.0233	0.0864	CbGeAlD
Pentoxifylline—PDE5A—endothelium—systemic scleroderma	0.0196	0.0729	CbGeAlD
Pentoxifylline—PDE5A—blood vessel—systemic scleroderma	0.0181	0.0673	CbGeAlD
Pentoxifylline—NT5E—connective tissue—systemic scleroderma	0.0143	0.0532	CbGeAlD
Pentoxifylline—NT5E—smooth muscle tissue—systemic scleroderma	0.0131	0.0486	CbGeAlD
Pentoxifylline—NT5E—skin of body—systemic scleroderma	0.0129	0.048	CbGeAlD
Pentoxifylline—ADORA2B—smooth muscle tissue—systemic scleroderma	0.0112	0.0416	CbGeAlD
Pentoxifylline—NT5E—tendon—systemic scleroderma	0.00984	0.0365	CbGeAlD
Pentoxifylline—PDE5A—connective tissue—systemic scleroderma	0.00929	0.0345	CbGeAlD
Pentoxifylline—NT5E—lung—systemic scleroderma	0.00863	0.0321	CbGeAlD
Pentoxifylline—PDE5A—smooth muscle tissue—systemic scleroderma	0.0085	0.0316	CbGeAlD
Pentoxifylline—ADORA2B—lung—systemic scleroderma	0.00739	0.0275	CbGeAlD
Pentoxifylline—PDE5A—digestive system—systemic scleroderma	0.00671	0.0249	CbGeAlD
Pentoxifylline—PDE4A—lung—systemic scleroderma	0.00659	0.0245	CbGeAlD
Pentoxifylline—PDE5A—tendon—systemic scleroderma	0.00638	0.0237	CbGeAlD
Pentoxifylline—ADORA1—tendon—systemic scleroderma	0.00605	0.0225	CbGeAlD
Pentoxifylline—PDE5A—lung—systemic scleroderma	0.0056	0.0208	CbGeAlD
Pentoxifylline—ADORA1—lung—systemic scleroderma	0.00531	0.0197	CbGeAlD
Pentoxifylline—PDE4B—tendon—systemic scleroderma	0.00448	0.0166	CbGeAlD
Pentoxifylline—PDE4B—lung—systemic scleroderma	0.00393	0.0146	CbGeAlD
Pentoxifylline—CYP1A2—digestive system—systemic scleroderma	0.00289	0.0107	CbGeAlD
Pentoxifylline—CYP1A2—lung—systemic scleroderma	0.00241	0.00896	CbGeAlD
Pentoxifylline—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.00116	0.00159	CcSEcCtD
Pentoxifylline—Discomfort—Lisinopril—systemic scleroderma	0.00116	0.00159	CcSEcCtD
Pentoxifylline—Dyspepsia—Leflunomide—systemic scleroderma	0.00115	0.00158	CcSEcCtD
Pentoxifylline—Vomiting—Mometasone—systemic scleroderma	0.00115	0.00157	CcSEcCtD
Pentoxifylline—Dry mouth—Lisinopril—systemic scleroderma	0.00115	0.00157	CcSEcCtD
Pentoxifylline—Feeling abnormal—Azathioprine—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Rash—Mometasone—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Asthenia—Captopril—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Dermatitis—Mometasone—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Decreased appetite—Leflunomide—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.00114	0.00156	CcSEcCtD
Pentoxifylline—Confusional state—Lisinopril—systemic scleroderma	0.00113	0.00155	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00113	0.00155	CcSEcCtD
Pentoxifylline—Headache—Mometasone—systemic scleroderma	0.00113	0.00155	CcSEcCtD
Pentoxifylline—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00155	CcSEcCtD
Pentoxifylline—Insomnia—Mycophenolic acid—systemic scleroderma	0.00113	0.00155	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00113	0.00154	CcSEcCtD
Pentoxifylline—Oedema—Lisinopril—systemic scleroderma	0.00113	0.00154	CcSEcCtD
Pentoxifylline—Pruritus—Captopril—systemic scleroderma	0.00112	0.00154	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00153	CcSEcCtD
Pentoxifylline—Constipation—Leflunomide—systemic scleroderma	0.00112	0.00153	CcSEcCtD
Pentoxifylline—Infection—Lisinopril—systemic scleroderma	0.00112	0.00153	CcSEcCtD
Pentoxifylline—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.00112	0.00153	CcSEcCtD
Pentoxifylline—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00111	0.00152	CcSEcCtD
Pentoxifylline—Somnolence—Mycophenolic acid—systemic scleroderma	0.00111	0.00152	CcSEcCtD
Pentoxifylline—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00111	0.00152	CcSEcCtD
Pentoxifylline—Shock—Lisinopril—systemic scleroderma	0.00111	0.00151	CcSEcCtD
Pentoxifylline—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0011	0.00151	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Lisinopril—systemic scleroderma	0.0011	0.00151	CcSEcCtD
Pentoxifylline—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.0011	0.0015	CcSEcCtD
Pentoxifylline—Tachycardia—Lisinopril—systemic scleroderma	0.0011	0.0015	CcSEcCtD
Pentoxifylline—Body temperature increased—Azathioprine—systemic scleroderma	0.0011	0.0015	CcSEcCtD
Pentoxifylline—Abdominal pain—Azathioprine—systemic scleroderma	0.0011	0.0015	CcSEcCtD
Pentoxifylline—Skin disorder—Lisinopril—systemic scleroderma	0.00109	0.0015	CcSEcCtD
Pentoxifylline—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00149	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00109	0.00149	CcSEcCtD
Pentoxifylline—Diarrhoea—Captopril—systemic scleroderma	0.00109	0.00149	CcSEcCtD
Pentoxifylline—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.00109	0.00149	CcSEcCtD
Pentoxifylline—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00108	0.00148	CcSEcCtD
Pentoxifylline—Feeling abnormal—Leflunomide—systemic scleroderma	0.00108	0.00148	CcSEcCtD
Pentoxifylline—Nausea—Mometasone—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Pentoxifylline—Anorexia—Lisinopril—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00107	0.00147	CcSEcCtD
Pentoxifylline—Constipation—Mycophenolic acid—systemic scleroderma	0.00107	0.00146	CcSEcCtD
Pentoxifylline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00107	0.00146	CcSEcCtD
Pentoxifylline—Hypotension—Lisinopril—systemic scleroderma	0.00105	0.00144	CcSEcCtD
Pentoxifylline—Dizziness—Captopril—systemic scleroderma	0.00105	0.00144	CcSEcCtD
Pentoxifylline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00105	0.00143	CcSEcCtD
Pentoxifylline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00143	CcSEcCtD
Pentoxifylline—Urticaria—Leflunomide—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Pentoxifylline—Abdominal pain—Leflunomide—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Pentoxifylline—Body temperature increased—Leflunomide—systemic scleroderma	0.00104	0.00142	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00103	0.00141	CcSEcCtD
Pentoxifylline—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00141	CcSEcCtD
Pentoxifylline—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00103	0.00141	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00103	0.0014	CcSEcCtD
Pentoxifylline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Pentoxifylline—Hypersensitivity—Azathioprine—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00102	0.0014	CcSEcCtD
Pentoxifylline—Insomnia—Lisinopril—systemic scleroderma	0.00102	0.00139	CcSEcCtD
Pentoxifylline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00102	0.00139	CcSEcCtD
Pentoxifylline—Vomiting—Captopril—systemic scleroderma	0.00101	0.00138	CcSEcCtD
Pentoxifylline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00138	CcSEcCtD
Pentoxifylline—Dyspnoea—Lisinopril—systemic scleroderma	0.001	0.00137	CcSEcCtD
Pentoxifylline—Rash—Captopril—systemic scleroderma	0.001	0.00137	CcSEcCtD
Pentoxifylline—Dermatitis—Captopril—systemic scleroderma	0.001	0.00137	CcSEcCtD
Pentoxifylline—Somnolence—Lisinopril—systemic scleroderma	0.001	0.00137	CcSEcCtD
Pentoxifylline—Headache—Captopril—systemic scleroderma	0.000995	0.00136	CcSEcCtD
Pentoxifylline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000994	0.00136	CcSEcCtD
Pentoxifylline—Dyspepsia—Lisinopril—systemic scleroderma	0.00099	0.00136	CcSEcCtD
Pentoxifylline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000988	0.00135	CcSEcCtD
Pentoxifylline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000988	0.00135	CcSEcCtD
Pentoxifylline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00135	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000986	0.00135	CcSEcCtD
Pentoxifylline—Infection—Mycophenolate mofetil—systemic scleroderma	0.000979	0.00134	CcSEcCtD
Pentoxifylline—Decreased appetite—Lisinopril—systemic scleroderma	0.000978	0.00134	CcSEcCtD
Pentoxifylline—Shock—Mycophenolate mofetil—systemic scleroderma	0.00097	0.00133	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000965	0.00132	CcSEcCtD
Pentoxifylline—Hypersensitivity—Leflunomide—systemic scleroderma	0.000965	0.00132	CcSEcCtD
Pentoxifylline—Constipation—Lisinopril—systemic scleroderma	0.000962	0.00132	CcSEcCtD
Pentoxifylline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000962	0.00132	CcSEcCtD
Pentoxifylline—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000958	0.00131	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000953	0.0013	CcSEcCtD
Pentoxifylline—Diarrhoea—Azathioprine—systemic scleroderma	0.000949	0.0013	CcSEcCtD
Pentoxifylline—Haemoglobin—Prednisone—systemic scleroderma	0.000945	0.00129	CcSEcCtD
Pentoxifylline—Nausea—Captopril—systemic scleroderma	0.000944	0.00129	CcSEcCtD
Pentoxifylline—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000942	0.00129	CcSEcCtD
Pentoxifylline—Haemorrhage—Prednisone—systemic scleroderma	0.000941	0.00129	CcSEcCtD
Pentoxifylline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00094	0.00129	CcSEcCtD
Pentoxifylline—Asthenia—Leflunomide—systemic scleroderma	0.00094	0.00129	CcSEcCtD
Pentoxifylline—Pancytopenia—Methotrexate—systemic scleroderma	0.000933	0.00128	CcSEcCtD
Pentoxifylline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000927	0.00127	CcSEcCtD
Pentoxifylline—Pruritus—Leflunomide—systemic scleroderma	0.000926	0.00127	CcSEcCtD
Pentoxifylline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000921	0.00126	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00092	0.00126	CcSEcCtD
Pentoxifylline—Dizziness—Azathioprine—systemic scleroderma	0.000917	0.00125	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000898	0.00123	CcSEcCtD
Pentoxifylline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000896	0.00123	CcSEcCtD
Pentoxifylline—Diarrhoea—Leflunomide—systemic scleroderma	0.000896	0.00123	CcSEcCtD
Pentoxifylline—Urticaria—Lisinopril—systemic scleroderma	0.000894	0.00122	CcSEcCtD
Pentoxifylline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000892	0.00122	CcSEcCtD
Pentoxifylline—Abdominal pain—Lisinopril—systemic scleroderma	0.00089	0.00122	CcSEcCtD
Pentoxifylline—Body temperature increased—Lisinopril—systemic scleroderma	0.00089	0.00122	CcSEcCtD
Pentoxifylline—Pruritus—Mycophenolic acid—systemic scleroderma	0.000884	0.00121	CcSEcCtD
Pentoxifylline—Vomiting—Azathioprine—systemic scleroderma	0.000882	0.00121	CcSEcCtD
Pentoxifylline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000879	0.0012	CcSEcCtD
Pentoxifylline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000876	0.0012	CcSEcCtD
Pentoxifylline—Drowsiness—Methotrexate—systemic scleroderma	0.000876	0.0012	CcSEcCtD
Pentoxifylline—Infestation NOS—Methotrexate—systemic scleroderma	0.000876	0.0012	CcSEcCtD
Pentoxifylline—Infestation—Methotrexate—systemic scleroderma	0.000876	0.0012	CcSEcCtD
Pentoxifylline—Rash—Azathioprine—systemic scleroderma	0.000874	0.0012	CcSEcCtD
Pentoxifylline—Dermatitis—Azathioprine—systemic scleroderma	0.000874	0.0012	CcSEcCtD
Pentoxifylline—Flushing—Prednisone—systemic scleroderma	0.000873	0.00119	CcSEcCtD
Pentoxifylline—Headache—Azathioprine—systemic scleroderma	0.000869	0.00119	CcSEcCtD
Pentoxifylline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000868	0.00119	CcSEcCtD
Pentoxifylline—Dizziness—Leflunomide—systemic scleroderma	0.000866	0.00119	CcSEcCtD
Pentoxifylline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000857	0.00117	CcSEcCtD
Pentoxifylline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000855	0.00117	CcSEcCtD
Pentoxifylline—Conjunctivitis—Methotrexate—systemic scleroderma	0.000851	0.00116	CcSEcCtD
Pentoxifylline—Immune system disorder—Prednisone—systemic scleroderma	0.00085	0.00116	CcSEcCtD
Pentoxifylline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000843	0.00115	CcSEcCtD
Pentoxifylline—Arrhythmia—Prednisone—systemic scleroderma	0.00084	0.00115	CcSEcCtD
Pentoxifylline—Sweating—Methotrexate—systemic scleroderma	0.00084	0.00115	CcSEcCtD
Pentoxifylline—Vomiting—Leflunomide—systemic scleroderma	0.000833	0.00114	CcSEcCtD
Pentoxifylline—Hypersensitivity—Lisinopril—systemic scleroderma	0.000829	0.00113	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000828	0.00113	CcSEcCtD
Pentoxifylline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000826	0.00113	CcSEcCtD
Pentoxifylline—Epistaxis—Methotrexate—systemic scleroderma	0.000826	0.00113	CcSEcCtD
Pentoxifylline—Rash—Leflunomide—systemic scleroderma	0.000826	0.00113	CcSEcCtD
Pentoxifylline—Dermatitis—Leflunomide—systemic scleroderma	0.000825	0.00113	CcSEcCtD
Pentoxifylline—Nausea—Azathioprine—systemic scleroderma	0.000824	0.00113	CcSEcCtD
Pentoxifylline—Headache—Leflunomide—systemic scleroderma	0.00082	0.00112	CcSEcCtD
Pentoxifylline—Erythema—Prednisone—systemic scleroderma	0.000819	0.00112	CcSEcCtD
Pentoxifylline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000812	0.00111	CcSEcCtD
Pentoxifylline—Asthenia—Lisinopril—systemic scleroderma	0.000807	0.0011	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000806	0.0011	CcSEcCtD
Pentoxifylline—Pruritus—Lisinopril—systemic scleroderma	0.000796	0.00109	CcSEcCtD
Pentoxifylline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000794	0.00109	CcSEcCtD
Pentoxifylline—Haemoglobin—Methotrexate—systemic scleroderma	0.00079	0.00108	CcSEcCtD
Pentoxifylline—Rash—Mycophenolic acid—systemic scleroderma	0.000788	0.00108	CcSEcCtD
Pentoxifylline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000787	0.00108	CcSEcCtD
Pentoxifylline—Haemorrhage—Methotrexate—systemic scleroderma	0.000786	0.00108	CcSEcCtD
Pentoxifylline—Hepatitis—Methotrexate—systemic scleroderma	0.000786	0.00108	CcSEcCtD
Pentoxifylline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000783	0.00107	CcSEcCtD
Pentoxifylline—Headache—Mycophenolic acid—systemic scleroderma	0.000783	0.00107	CcSEcCtD
Pentoxifylline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000779	0.00107	CcSEcCtD
Pentoxifylline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000779	0.00107	CcSEcCtD
Pentoxifylline—Nausea—Leflunomide—systemic scleroderma	0.000778	0.00106	CcSEcCtD
Pentoxifylline—Vision blurred—Prednisone—systemic scleroderma	0.000772	0.00106	CcSEcCtD
Pentoxifylline—Diarrhoea—Lisinopril—systemic scleroderma	0.00077	0.00105	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Prednisone—systemic scleroderma	0.00076	0.00104	CcSEcCtD
Pentoxifylline—Anaemia—Prednisone—systemic scleroderma	0.000757	0.00104	CcSEcCtD
Pentoxifylline—Agitation—Prednisone—systemic scleroderma	0.000752	0.00103	CcSEcCtD
Pentoxifylline—Angioedema—Prednisone—systemic scleroderma	0.000748	0.00102	CcSEcCtD
Pentoxifylline—Dizziness—Lisinopril—systemic scleroderma	0.000744	0.00102	CcSEcCtD
Pentoxifylline—Nausea—Mycophenolic acid—systemic scleroderma	0.000742	0.00102	CcSEcCtD
Pentoxifylline—Malaise—Prednisone—systemic scleroderma	0.000738	0.00101	CcSEcCtD
Pentoxifylline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000726	0.000994	CcSEcCtD
Pentoxifylline—Vomiting—Lisinopril—systemic scleroderma	0.000715	0.000979	CcSEcCtD
Pentoxifylline—Immune system disorder—Methotrexate—systemic scleroderma	0.00071	0.000972	CcSEcCtD
Pentoxifylline—Rash—Lisinopril—systemic scleroderma	0.000709	0.000971	CcSEcCtD
Pentoxifylline—Convulsion—Prednisone—systemic scleroderma	0.000709	0.000971	CcSEcCtD
Pentoxifylline—Dermatitis—Lisinopril—systemic scleroderma	0.000709	0.00097	CcSEcCtD
Pentoxifylline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000707	0.000968	CcSEcCtD
Pentoxifylline—Hypertension—Prednisone—systemic scleroderma	0.000707	0.000967	CcSEcCtD
Pentoxifylline—Headache—Lisinopril—systemic scleroderma	0.000705	0.000965	CcSEcCtD
Pentoxifylline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000698	0.000955	CcSEcCtD
Pentoxifylline—Myalgia—Prednisone—systemic scleroderma	0.000697	0.000954	CcSEcCtD
Pentoxifylline—Anxiety—Prednisone—systemic scleroderma	0.000695	0.000951	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000692	0.000947	CcSEcCtD
Pentoxifylline—Discomfort—Prednisone—systemic scleroderma	0.000689	0.000943	CcSEcCtD
Pentoxifylline—Erythema—Methotrexate—systemic scleroderma	0.000684	0.000936	CcSEcCtD
Pentoxifylline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000675	0.000923	CcSEcCtD
Pentoxifylline—Dysgeusia—Methotrexate—systemic scleroderma	0.00067	0.000917	CcSEcCtD
Pentoxifylline—Nausea—Lisinopril—systemic scleroderma	0.000668	0.000915	CcSEcCtD
Pentoxifylline—Oedema—Prednisone—systemic scleroderma	0.000668	0.000915	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Prednisone—systemic scleroderma	0.000668	0.000915	CcSEcCtD
Pentoxifylline—Infection—Prednisone—systemic scleroderma	0.000664	0.000909	CcSEcCtD
Pentoxifylline—Back pain—Methotrexate—systemic scleroderma	0.000662	0.000906	CcSEcCtD
Pentoxifylline—Shock—Prednisone—systemic scleroderma	0.000657	0.0009	CcSEcCtD
Pentoxifylline—Tachycardia—Prednisone—systemic scleroderma	0.000652	0.000893	CcSEcCtD
Pentoxifylline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000652	0.000892	CcSEcCtD
Pentoxifylline—Skin disorder—Prednisone—systemic scleroderma	0.000649	0.000888	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000646	0.000884	CcSEcCtD
Pentoxifylline—Vision blurred—Methotrexate—systemic scleroderma	0.000645	0.000883	CcSEcCtD
Pentoxifylline—Anorexia—Prednisone—systemic scleroderma	0.000637	0.000872	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000635	0.000869	CcSEcCtD
Pentoxifylline—Anaemia—Methotrexate—systemic scleroderma	0.000633	0.000866	CcSEcCtD
Pentoxifylline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000627	0.000858	CcSEcCtD
Pentoxifylline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000622	0.000851	CcSEcCtD
Pentoxifylline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000621	0.00085	CcSEcCtD
Pentoxifylline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000618	0.000845	CcSEcCtD
Pentoxifylline—Malaise—Methotrexate—systemic scleroderma	0.000617	0.000845	CcSEcCtD
Pentoxifylline—Leukopenia—Methotrexate—systemic scleroderma	0.000613	0.000838	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000609	0.000833	CcSEcCtD
Pentoxifylline—Insomnia—Prednisone—systemic scleroderma	0.000604	0.000827	CcSEcCtD
Pentoxifylline—Convulsion—Methotrexate—systemic scleroderma	0.000593	0.000811	CcSEcCtD
Pentoxifylline—Dyspepsia—Prednisone—systemic scleroderma	0.000588	0.000805	CcSEcCtD
Pentoxifylline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000586	0.000801	CcSEcCtD
Pentoxifylline—Myalgia—Methotrexate—systemic scleroderma	0.000583	0.000797	CcSEcCtD
Pentoxifylline—Chest pain—Methotrexate—systemic scleroderma	0.000583	0.000797	CcSEcCtD
Pentoxifylline—Decreased appetite—Prednisone—systemic scleroderma	0.000581	0.000795	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000579	0.000792	CcSEcCtD
Pentoxifylline—Discomfort—Methotrexate—systemic scleroderma	0.000576	0.000788	CcSEcCtD
Pentoxifylline—Constipation—Prednisone—systemic scleroderma	0.000571	0.000782	CcSEcCtD
Pentoxifylline—Confusional state—Methotrexate—systemic scleroderma	0.000563	0.000771	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000559	0.000764	CcSEcCtD
Pentoxifylline—Infection—Methotrexate—systemic scleroderma	0.000555	0.000759	CcSEcCtD
Pentoxifylline—Feeling abnormal—Prednisone—systemic scleroderma	0.000551	0.000754	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000547	0.000748	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000546	0.000748	CcSEcCtD
Pentoxifylline—Skin disorder—Methotrexate—systemic scleroderma	0.000542	0.000742	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00054	0.000739	CcSEcCtD
Pentoxifylline—Anorexia—Methotrexate—systemic scleroderma	0.000532	0.000729	CcSEcCtD
Pentoxifylline—Urticaria—Prednisone—systemic scleroderma	0.000531	0.000727	CcSEcCtD
Pentoxifylline—Body temperature increased—Prednisone—systemic scleroderma	0.000528	0.000723	CcSEcCtD
Pentoxifylline—Abdominal pain—Prednisone—systemic scleroderma	0.000528	0.000723	CcSEcCtD
Pentoxifylline—Hypotension—Methotrexate—systemic scleroderma	0.000522	0.000714	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000509	0.000696	CcSEcCtD
Pentoxifylline—Insomnia—Methotrexate—systemic scleroderma	0.000505	0.000691	CcSEcCtD
Pentoxifylline—Dyspnoea—Methotrexate—systemic scleroderma	0.000498	0.000681	CcSEcCtD
Pentoxifylline—Somnolence—Methotrexate—systemic scleroderma	0.000497	0.000679	CcSEcCtD
Pentoxifylline—Hypersensitivity—Prednisone—systemic scleroderma	0.000492	0.000674	CcSEcCtD
Pentoxifylline—Dyspepsia—Methotrexate—systemic scleroderma	0.000492	0.000673	CcSEcCtD
Pentoxifylline—Decreased appetite—Methotrexate—systemic scleroderma	0.000486	0.000664	CcSEcCtD
Pentoxifylline—Asthenia—Prednisone—systemic scleroderma	0.000479	0.000656	CcSEcCtD
Pentoxifylline—Pruritus—Prednisone—systemic scleroderma	0.000473	0.000647	CcSEcCtD
Pentoxifylline—Feeling abnormal—Methotrexate—systemic scleroderma	0.00046	0.00063	CcSEcCtD
Pentoxifylline—Diarrhoea—Prednisone—systemic scleroderma	0.000457	0.000626	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000457	0.000625	CcSEcCtD
Pentoxifylline—Urticaria—Methotrexate—systemic scleroderma	0.000444	0.000607	CcSEcCtD
Pentoxifylline—Dizziness—Prednisone—systemic scleroderma	0.000442	0.000605	CcSEcCtD
Pentoxifylline—Abdominal pain—Methotrexate—systemic scleroderma	0.000442	0.000604	CcSEcCtD
Pentoxifylline—Body temperature increased—Methotrexate—systemic scleroderma	0.000442	0.000604	CcSEcCtD
Pentoxifylline—Vomiting—Prednisone—systemic scleroderma	0.000425	0.000581	CcSEcCtD
Pentoxifylline—Rash—Prednisone—systemic scleroderma	0.000421	0.000577	CcSEcCtD
Pentoxifylline—Dermatitis—Prednisone—systemic scleroderma	0.000421	0.000576	CcSEcCtD
Pentoxifylline—Headache—Prednisone—systemic scleroderma	0.000419	0.000573	CcSEcCtD
Pentoxifylline—Hypersensitivity—Methotrexate—systemic scleroderma	0.000411	0.000563	CcSEcCtD
Pentoxifylline—Asthenia—Methotrexate—systemic scleroderma	0.000401	0.000548	CcSEcCtD
Pentoxifylline—Nausea—Prednisone—systemic scleroderma	0.000397	0.000543	CcSEcCtD
Pentoxifylline—Pruritus—Methotrexate—systemic scleroderma	0.000395	0.000541	CcSEcCtD
Pentoxifylline—Diarrhoea—Methotrexate—systemic scleroderma	0.000382	0.000523	CcSEcCtD
Pentoxifylline—Dizziness—Methotrexate—systemic scleroderma	0.000369	0.000505	CcSEcCtD
Pentoxifylline—Vomiting—Methotrexate—systemic scleroderma	0.000355	0.000486	CcSEcCtD
Pentoxifylline—Rash—Methotrexate—systemic scleroderma	0.000352	0.000482	CcSEcCtD
Pentoxifylline—Dermatitis—Methotrexate—systemic scleroderma	0.000352	0.000481	CcSEcCtD
Pentoxifylline—Headache—Methotrexate—systemic scleroderma	0.00035	0.000479	CcSEcCtD
Pentoxifylline—Nausea—Methotrexate—systemic scleroderma	0.000332	0.000454	CcSEcCtD
